Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Update Il y a 5 ans
Reference: NCT01463982

Woman and Man

Extract

The main objective of this study is to determine the maximum tolerated dose (MTD) of Oratecan in combination with capecitabine


Inclusion criteria

  • Solid tumor ,advanced cancer

Links